Perceived control attitude among heart failure patients in Oman: a multicenter study

Maryam Alharrasi1, Huda Al-Noumani2, Amal Al-Ghassani3

  • 1College of Nursing, Sultan Qaboos University, Alkhoud, BO. Box 66, Muscat, Oman. maryam22@squ.edu.om.

Scientific Reports
|August 7, 2024
PubMed

Insights

Perceived control in heart failure patients in Oman was adequate. Female gender, older age, smoking, current health status, higher ejection fraction, and comorbidities were linked to perceived control. Interventions can improve patient quality of life.

Area of Science:

  • Cardiology
  • Psychology
  • Public Health

Background:

  • Heart failure (HF) is a global health issue affecting over 64.3 million people worldwide.
  • Increasing HF prevalence is linked to an aging population, improved survival post-myocardial infarction, and conditions like hypertension and diabetes mellitus.
  • Perceived control, a modifiable factor, can enhance self-care behaviors and improve health outcomes in patients with chronic conditions.

Purpose of the Study:

  • To investigate factors influencing perceived control attitudes among heart failure patients in Oman.
  • To assess the relationship between demographic, clinical, and lifestyle factors and perceived control in this population.

Main Methods:

  • A cross-sectional study was conducted with 180 heart failure patients in Oman.
  • Perceived control attitude was measured, and its association with various factors including gender, age, smoking status, current health, ejection fraction, and comorbidities was analyzed.

Main Results:

  • The mean perceived control attitude score was 16.97 ± 2.25, indicating adequate levels.
  • Significant factors associated with perceived control included female gender (p=0.006), older age (p<0.001), smoking (p<0.001), current health status (p<0.001), higher ejection fraction (p=0.008), and comorbidities (p=0.026).

Conclusions:

  • Perceived control among heart failure patients in Oman is generally adequate, but influenced by several demographic and clinical factors.
  • Interventions focusing on attitudes, barriers, and social support may further enhance perceived control.
  • Clinicians should assess and manage perceived control to optimize quality of life for heart failure patients.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
548
Heart Failure Drugs: &#946;-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
326
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
406
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
293
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K